comparemela.com
Latest Breaking News On - Novel hedgehog inhibitor - Page 1 : comparemela.com
Dr Paul Frohna Discusses Promising Results of Novel Hedgehog Inhibitor for IPF
Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul Frohna, MD, PhD, PharmD.
California
United-states
San-diego
American
Paul-frohna
American-thoracic-society
International-conference
Endeavor-biomedicines
Novel-hedgehog-inhibitor
Increases-lung-function
Reduces-lung-fibrosis
Results-from
vimarsana © 2020. All Rights Reserved.